Controversy Around FDA’s Approval of Biogen Alzheimer’s Drug, Aducanumab - a podcast by Michael Greger M.D. FACLM

from 2023-10-23T11:50:36

:: ::

I discuss the safety and efficacy of the newest Alzheimer's drug treatments, aducanumab (Aduhelm) and lecanemab (Leqembi).